Overview

Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study will examine the effect of statin and niacin therapy on carotid plaque biomarkers
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Atorvastatin
Atorvastatin Calcium
Niacin
Niacinamide
Nicotinic Acids
Simvastatin